Swiss regulators said Wednesday that data submitted by AstraZeneca were not yet sufficient for it to authorise use of the Anglo-Swedish firm's COVID-19 vaccine and "new studies" were needed.
Feb 03, 2021
0
7
Switzerland gave the green light Tuesday to the Moderna vaccine against the new coronavirus—after being the first country in continental Europe to start using the Pfizer-BioNTech jab.
Jan 12, 2021
0
4
Peru has temporarily suspended clinical trials of a COVID vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.
Dec 12, 2020
0
267
Despite not having safety and efficacy data from the final phase of clinical trials, China and Russia have already started COVID-19 vaccinations and have been widely criticized for prematurely exposing the public to these ...
Nov 06, 2020
0
35
Scientific advances have transformed the prevention, treatment and cure of many diseases globally. However, millions of Africans continue to die, endure long periods of illnesses—and suffer negative impacts of diseases ...
Sep 16, 2020
0
2
One of the hottest topics around COVID-19 is the need for a vaccine for this new disease, which has had a huge impact on both human health and economies. The disease caught most people completely by surprise and shows no ...
Sep 11, 2020
0
3
Face masks are thought to slow the spread of viruses, including the novel coronavirus that causes COVID-19, but little is known about how well they work.
Jun 16, 2020
1
377
(HealthDay)—In an evidence-based guideline developed by an international team of physicians, pharmacists, researchers, and patients, published online April 29 in CMAJ, the journal of the Canadian Medical Association, recommendations ...
May 06, 2020
0
9
Is it possible to improve clinical practice and patient outcomes by using vast amounts of healthcare data? Considering that such information is scattered across multiple institutions and countries, stored in different formats ...
Apr 01, 2020
0
0
The pharmaceutical industry expects it will take 12 to 18 months to roll out a coronavirus vaccine, executives said Thursday, as they jointly pledged to make it available worldwide based on need.
Mar 19, 2020
1
459
